New Jersey Attorneys Who Get Results

New Jersey Attorney, New Jersey Medical Malpractice Attorney, NJ Personal Injury Lawyers

Meet Gary Shapiro and David Sternlieb, two experienced New Jersey attorneys who know how to get results. At Shapiro & Sternlieb, we are 100% dedicated to providing our clients with the highest quality legal representation. Through our hard work, persistence and with more than 60 years of combined legal experience, we work hard to protect your rights. As expert lawyers, we have the resources and knowledge to handle complex cases. We pride ourselves on our concern for you as an individual as well as for your legal rights.

Shapiro & Sternlieb: New Jersey Personal Injury Lawyers

auto accident lawyer ,NJ Personal Injury Lawyers, New Jersey Medical Malpractice Attorney

At Shapiro & Sternlieb, your case is our priority. Our attorneys combine outstanding client services with a thorough knowledge of the law and a firm understanding of the latest technology available. Our vast network of legal, medical and professional experts are available to present the best case for you. Located in Manalapan, New Jersey, our lawyers maintain flexible hours to meet your needs. We offer morning, evening or weekend hours, as well as visits to home or hospital, if needed. Our attorneys and staff bring the highest standards of expertise, preparation, concern, diligence, integrity and skill to each case. We take time to return your calls and to ensure each question is answered. You are included every step of the way!

News & Articles

Salmonella Outbreak Linked To Tainted Peanut Butter
CARBON NANOTUBES: A Closer Look at Miracle Technology's Potential Side Effects

Practice Areas

AsbestosInfant & Child Injuries
Auto AccidentsDUI (DWI) Matters
DiscriminationBirth Injuries
Defective ProductsBrain Injury
Burn InjuriesCerebral Palsy
Criminal DefenseClass Action Lawsuits
Construction AccidentsDog Bites
Erbs PalsyFailure To Diagnose Cancer
Gas ExplosionsHead Injury
Juvenile CourtLung Cancer - Mesothelioma
Medical MalpracticeMotorcycle Accidents
NegligenceNegligent Security
Nursing Home AbusePersonal Injury
Premises LiabilitySexual Harassment
Slip & Fall AccidentsTraffic Violations
Truck AccidentsWorkplace Injuries
Wrongful Discharge

FDA Consumer Health Information Updates

5 Tips for Traveling to the U.S. With Medications

Tue, 02 Feb 2016 08:00:00 -0500

Can you bring foreign drugs into the U.S.? Or refill a foreign prescription at a U.S. pharmacy? FDA can help you understand the rules for flying with medications or shipping them from overseas.

Heartworm Prevention in Your Pet 

Wed, 27 Jan 2016 08:46:00 -0500

Heartworm is difficult to treat but can be prevented with drugs approved by FDA.

Improving Your Odds for Cervical Health

Thu, 21 Jan 2016 11:43:00 -0500

Cervical cancer is largely preventable and, if detected early, curable. The keys to cervical health come down to two kinds of tests evaluated by FDA. Learn the role FDA plays and what you can do to maximize your cervical health.

FDA's Smoking Prevention Campaigns: Reaching Teens Where They 'Live'

Wed, 13 Jan 2016 08:00:00 -0500

FDA uses innovative public education campaigns to educate youth about the dangers of smoking.

Shoring Up the Still-Emerging Science of Neonatology

Wed, 06 Jan 2016 08:00:00 -0500

A conversation with FDA's newest neonatologist, Gerri Baer

Food and Drug Administration--Press Releases

FDA seeks $5.1 billion total for FY 2017, including funds to implement food safety law, improve medical product safety and quality

Tue, 09 Feb 2016 13:33:00 -0500

The U.S. Food and Drug Administration is requesting a total budget of $5.1 billion to protect and promote the public health as part of the President’s fiscal year (FY) 2017 budget – an eight percent increase over the enacted budget for FY 2016. The overall request includes a net increase of $14.6 million in budget authority and $268.7 million in user fees for initiatives tied to several key areas, including the implementation of the FDA Food Safety Modernization Act (FMSA) and efforts to improve medical product safety and quality. The agency is also seeking $75 million in new mandatory funding to support the National Cancer Moonshot initiative being led by the Vice President.

Califf, FDA top officials call for sweeping review of agency opioids policies

Thu, 04 Feb 2016 15:00:00 -0500

In response to the opioid abuse epidemic, today Dr. Robert Califf, the FDA’s Deputy Commissioner for Medical Products and Tobacco, along with other FDA leaders, called for a far-reaching action plan to reassess the agency’s approach to opioid medications. The plan will focus on policies aimed at reversing the epidemic, while still providing patients in pain access to effective relief.

FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4

Thu, 28 Jan 2016 17:52:00 -0500

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.

FDA approves first drug to show survival benefit in liposarcoma

Thu, 28 Jan 2016 13:00:00 -0500

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug.

FDA resolves criminal and civil actions against cheese manufacturer

Fri, 22 Jan 2016 17:30:00 -0500

Delaware-based cheese manufacturer Roos Foods, Inc. has pleaded guilty to one criminal misdemeanor count of violating the Federal Food, Drug, and Cosmetic Act (FFDCA) by introducing adulterated food into interstate commerce.